Company intelligence / Profile preview

EFISHient Protein

Israel

Ownership: Private
Employees: ~10
Development stage: Other

Overview

EFISHient Protein is an Israeli B2B FoodTech/biotech company partnered with BioMeat FoodTech and the Volcani Institute, focusing on pioneering sustainable cell-based and plant-based white fish protein products—most notably cultivated tilapia and plant-based grouper—using advanced cell culture and biotechnology systems for alternative, scalable seafood protein. The company operates pilot manufacturing facilities and intends to empower large-scale food producers, with commercialization focused first on plant-based offerings as it continues to seek regulatory approval for cultivated products.

Modalities: Recombinant proteinCell-cultured proteinPlant-based protein
Industry: Non-Drug Biotech

Partnerships

BioMeat FoodTechVolcani Institute

Beyond the preview

Go deeper on EFISHient Protein.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EFISHient Protein.

Explore the full profile